Gilead's stock rallies and AstraZeneca falls, after reports of preliminary merger interest, which have been droppedMarket Watch • 06/08/20
Oxford Biomedica partners with VMIC to ramp up production of AstraZeneca’s experimental COVID-19 vaccineInvezz • 06/08/20
British Drug Maker AstraZeneca Approached Gilead With The Deal That Can Become The Biggest On The RecordBenzinga • 06/08/20
AstraZeneca to Produce 2 Billion Doses of Its Coronavirus Vaccine CandidateThe Motley Fool • 06/04/20
AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine — and it could be ready by SeptemberCNBC • 06/04/20
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to SupportThe Motley Fool • 06/03/20
AstraZeneca Scored A 'Home Run' With Its Cancer Drug — And Shares PoppedInvestors Business Daily • 05/29/20